A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity

Although neoantigens are one of the most favorable targets in cancer immunotherapy, it is less versatile and costly to apply neoantigen‐derived cancer vaccines to patients due to individual variation. It is, therefore, important to find highly immunogenic antigens between tumor‐specific or associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajima, Yuki, Kosaka, Akemi, Ishibashi, Kei, Yasuda, Shunsuke, Komatsuda, Hiroki, Nagato, Toshihiro, Oikawa, Kensuke, Kitada, Masahiro, Takekawa, Masanori, Kumai, Takumi, Ohara, Kenzo, Ohkuri, Takayuki, Kobayashi, Hiroya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357613/
https://www.ncbi.nlm.nih.gov/pubmed/35579200
http://dx.doi.org/10.1111/cas.15429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357613/
https://www.ncbi.nlm.nih.gov/pubmed/35579200
http://dx.doi.org/10.1111/cas.15429

Ejemplares similares